Glucocorticosteroids have an inhibitory effect on the expression of interleukin 2 (IL-2) and interleukin 2 receptor (IL-2R) genes. To determine the mechanisms of this inhibition, human T lymphocytes were stimulated with mitogens in the presence of dexamethasone. Nuclear transcription run-off assays showed that high doses of dexamethasone inhibited the transcription of the IL-2 gene but not that of the IL-2R gene. Posttranscriptionally, high doses of dexamethasone (lo-4 M) were required to inhibit IL-2R mRNA levels by 50%, whereas lower doses (10-6 M) inhibited by > 70% the accumulation of IL-2 mRNA. IL-2 mRNA half-life decreased in the presence ofdexamethasone (10-' M) by -50%. At the protein product level, dexamethasone inhibited both IL-2 production, as well as cell surface and soluble forms of IL-2R. IL-2R gene expression was inhibited for at least 72 h after exposure of cells to dexamethasone. In the presence of exogenous IL-2, dexamethasone failed to exert a significant effect on the production of IL-2R protein.
Introduction
Stimulation of T cells by antigens or mitogens leads to synthesis of interleukin 2 (IL-2) and receptors for IL-2 (IL-2R)' (1) . After activation with phytohemagglutinin (PHA), the number of IL-2R peaks within 48-72 h and then declines. This rise and fall in IL-2R gene expression is paralleled by changes in T cell proliferation. Thus, the regulation ofboth IL-2 and IL-2R gene expression is critically involved in the control of T cell growth and the normal immune response (1, 2).
High-affinity IL-2R have been found to consist of two dis-tinct polypeptide chains, each of which contains an IL-2 binding site (1, 3) . The larger IL-2 binding protein (75 kD) is designated as the # chain, whereas the smaller protein (55 kD, Tac antigen) is termed the a chain. Each chain reacts with IL-2 very differently; IL-2 binds and dissociates from p75 ,3 chains slowly, whereas it reacts very rapidly with p55 a chains. When paired, these two lower-affinity ligand-binding proteins result in a very high-affinity IL-2 receptor. Interestingly, only binding of IL-2 through the p75 ,B chains stimulates T cell proliferation (1) . Synthesis of IL-2 and the IL-2R p55 chains is regulated at least in part at the level of DNA transcription (2, 4, 5) . However, the regulation of IL-2R p55 differs from the regulation of its ligand, IL-2: both an increase of cytoplasmic free calcium
[Ca2+]i and activation of protein kinase C are required to activate transcription of the IL-2 gene in resting T cells. Reagents that activate protein kinase C are sufficient and more potent than those that only increase [Ca2+] i in the induction of p55 gene expression (3, 6) . IL-2 itself up-regulates the expression of IL-2R p55 via a transcriptional mechanism (7, 8) . The induction of IL-2R p55 expression by phorbol esters is not inhibitable by cyclosporine A, a potent inhibitor of IL-2 transcription (9) . Taken together, these studies suggest that the regulation of IL-2 is more stringent than is the regulation of its receptor (10) .
Dexamethasone, a synthetic glucocorticosteroid hormone, is a potent inhibitor of T cell proliferation induced by antigens and mitogens (1 1, 12) . Dexamethasone inhibits the PHA-induced mRNA accumulation for IL-2 and IL-2R p55, as well as the IL-2 protein product and the expression ofboth the high-affinity and the low-affinity forms of IL-2R (11) (12) (13) (14) . However, previous investigations ofthe effect ofdexamethasone on transcription of IL-2 and IL-2R p55 genes have relied either on unfractionated peripheral blood mononuclear cells (PBMC) (14) , or on indirect methods, such as mRNA blotting, which do not distinguish between transcriptional and post-transcriptional effects (11, 14) .
To date, the effects of dexamethasone on the nuclear transcription of IL-2 and IL-2R p55 genes have not been defined. We therefore investigated the effect of dexamethasone on the mitogen-induced expression of IL-2 and IL-2R p55 genes in pure human peripheral blood T cells by nuclear run-off assays, mRNA blotting, and determinations ofthe IL-2 and p55 chain IL-2R gene products. Our data indicate that dexamethasone inhibits the nuclear transcription of IL-2 but not of the IL-2R gene. IL-2 gene expression is far more sensitive to the inhibitory effect of dexamethasone than is its receptor gene. Dexamethasone also decreases IL-2 expression by decreasing the stability of IL-2 mRNA. Finally, we present data suggesting that the inhibitory effect of dexamethasone on IL-2R p55 expression may be indirect, resulting from inhibition ofIL-2 production. Soluble IL-2R assay. Soluble IL-2R were determined by a "sandwich" enzyme-linked immunosorbent assay (ELISA) which employs two monoclonal antibodies (anti-Tac and 7G7/B6) that recognize distinct epitopes on the human IL-2R as described (15) . In brief, alternate rows of the inner 60 wells of flat-bottomed 96-well microtiter plates (Immulon-1, Dynatech Laboratories, Inc., Alexandria, VA) were coated overnight with 150 Ml ofpurified anti-Tac at 1 Mg/ml in carbonate buffer, pH 9.6, or carbonate buffer alone as a background control. After washing, 100 ,ul of various dilutions of samples was added to the coated and control wells, incubated for 2 h, and washed; 100 ,l of a 1/4,000 dilution of FITC-conjugated 7G7/B6 in phosphate-buffered saline containing 1% FCS was added to all the wells. After an additional 2-h incubation, the plates were washed, and 100 Ml ofa 1/1,000 dilution of alkaline phosphatase-conjugated rabbit anti-FITC was added. After a 1-h incubation, the plates were washed, 100 ,ul ofp-nitrophenyl phosphate (1 mg/ml, Sigma Chemical Co.) was added, and the absorbance of the wells was determined after 30 min at 405 nm by using a Titertek ELISA reader (Flow Laboratories, Inc., Rockville, MD). A reference reagent, consisting ofthe cell-free supernatant ofa normal IL-2-dependent human T cell line, 4 d after stimulation with 10% IL-2 (Cellular Products, Buffalo, NY), was used in all ofthese studies. The undiluted supernatant was assigned a value of 1,000 IL-2R U/ml, and the absorbance values as determined by ELISA of serial dilutions of this supernatant were used to generate a reference curve. The absorbance of the test wells were then compared with the standard curve and were converted to a numerical value.
RNA isolation. Pelleted PBMC were lysed with a denaturing solution containing 4 M guanidinium thiocyanate (Fluka, Buchs, Switzerland), 25 mM sodium citrate, pH 7.0 (Mallinckrodt, Inc., Paris, KY), 0.5% sarcosyl, and 0.1 M 2-mercaptoethanol (Sigma Chemical Co.), and homogenized immediately, as described (16). Briefly, 80-100 X 106 E+ cells were lysed with 3 ml ofthe denaturing solution, homogenized at room temperature, and transferred to a 12-ml polypropylene tube. Subsequently, 0.3 ml of 2 M sodium acetate (pH 4.0), 3 ml of phenol (water-saturated; Bethesda Research Laboratories, Gaithersburg, MD), and 0.6 ml of chloroform-isoamyl alcohol mixture (49:1) were added to the homogenate. The final suspension was shaken vigorously for 10 s, cooled on ice for 15 min, and centrifuged at 10,000 g for 20 min at 4°C.
The aqueous phase was collected in a new tube, mixed with 2 vol of absolute ethanol, and placed on dry ice for at least 20 min to precipitate RNA. This was followed by centrifugation at 10,000 g for 20 min. The RNA pellet was dissolved in 0.5 ml of the denaturing solution, transferred into a 1 .5-ml Eppendorftube, precipitated with 2 vol ofabsolute ethanol on dry ice for 20 min, and centrifuged in an Eppendorfcentrifuge for 10 min at 4°C. The RNA pellet was resuspended in 75% ethanol, sedimented, vacuum-dried, dissolved in 40 ,l of 0.5% sodium dodecyl sulfate (SDS) at 65°C for 10 min, and quantitated by absorbance at 260 nm.
Northern blot analysis. Total RNA was denatured at 100°C for 2 min in an electrophoresis buffer (0. gg/lane) through 1% agarose gels containing 6% formaldehyde. The gels were then stained with ethidium bromide to assure integrity of the loaded RNA. RNA was transferred to nylon membranes (Gene Screen Plus, New England Nuclear, Boston, MA) and baked for 2 h at 80C in a vacuum oven. Membranes were prehybridized and hybridized with the following 32P-labeled complementary DNA probes: (a) a 700-bp fragment of IL-2 containing the Stul and XbaI sites of human IL-2 (Oncor, Gaithersburg, MD), (b) a 320-bp PstI-AvaII fragment of the fourth exon of human IL-2R (p55 chain, Oncor), and (c) 1.4-kb PstI fragment of a glyceraldehyde 3-phosphate dehydrogenase (GAPDH) (17) and human fl-actin (Lofstrand Laboratories, Gaithersburg, MD) which served as control probes. They were hybridized in a solution containing 1% SDS (Bio-Rad Laboratories, Richmond, CA), 1 M NaCl, 10% dextran sulfate (Pharmacia, Inc.), 50 mM Tris, pH 7.5 (Bethesda Research Laboratories), and 250 gg/ml salmon sperm DNA (Pharmacia, Inc.), at 650C overnight. The filters were then washed twice with 2x SSC (lx SSC = 0.015 M sodium citrate, 0.15 M NaCl, pH 7) at 250C, twice with 2x SSC and 1% SDS at 650C, and twice with 0.1X SSC at 250C for 30 min. They were then exposed to XAR-2 films (Eastman Kodak Co., Rochester, NY) at -70'C in the presence of intensifying screens. After development, the intensities ofthe bands on the films were quantitated by scanning densitometry.
Nuclear run-offtranscription assays. Nuclei were isolated by incubating the cells on ice in lysing solution containing 10 mM Tris (pH 8.0), 10 mM MgCI2, 1 mM dithiothreitol (DTT; Sigma Chemical Co.), and 0.1% Nonidet P40 (Sigma Chemical Co.) (18) . The nuclei were then centrifuged, and the pellet was resuspended in lysis solution without NP40 containing 10 gg/ml RNase A (Bethesda Research Laboratories), incubated on ice for 20 min, and then layered onto 30% sucrose in lysis solution and centrifuged at 400 g for 10 min. The nuclei were counted, and 60-80 X 106 nuclei were incubated in 100 ul ofa solution (1 1-13 ). As shown in Fig. 1 10 ' M even with prolonged incubation (data not shown). In order to determine whether the inhibition of IL-2R p55 expression indirectly resulted from decreased IL-2 production, PBMC were stimulated with PHA and high doses of dexamethasone (10-4 M) in the presence of IL-2 (20 U/ml). As shown in Fig. 3 , in the presence of exogenous IL-2, there was no demonstrable inhibition of IL-2R p55 expression by dexamethasone. 
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The duration of the inhibitory effect of dexamethasone on IL-2R p55 expression was assessed by the following experiment. E+ cells were incubated for 8 h with dexamethasone 1O M, washed with medium three times in order to remove the unbound dexamethasone, and incubated for 3 d at 370C. Cells were subsequently stimulated with PHA and IL-2R p55 was determined 24, 48, and 72 h later. As shown in Fig. 4 corresponding to a truncated form of the p55 chain ofthe cellassociated IL-2R. Soluble IL-2R has been shown to be present in the culture supernatants ofactivated normal lymphocytes as well as oftumor lines ofT cell and B cell lineage (15) . Supernatants of 24 h cultures of E+ cells stimulated with PHA and/or PMA in the presence of various concentrations of dexamethasone (l0-4 to 10-6 M), were assayed for soluble IL-2R by the "sandwich" ELISA, which employs two monoclonal antibodies, anti-Tac and 7G7B6, that recognize distinct epitopes on the human IL-2R (15) . Dexamethasone inhibited the soluble IL-2R in the supernatants ofcell cultures stimulated with PHA alone or with PMA. Fig. 5 shows the results from the quantitation of soluble IL-2R in the supernatants of E+ cells cultured with PHA for 24 h in the presence of various concentrations of dexamethasone. Medium alone or medium with dexamethasone resulted in < 32 U/ml in our assay. As shown in Fig. 5 , dexamethasone inhibited the release ofsoluble IL-2R in a dosedependent fashion.
IL-2 and IL-2R gene transcription. Having demonstrated dexamethasone inhibition ofIL-2 and IL-2R p55 chain production, we then investigated the mechanism underlying this effect. Since glucocorticosteroid hormones regulate the expression of several genes directly at a transcriptional level ( 19) , we first examined the effects of dexamethasone on the transcription of IL-2 and IL-2R p55 genes by nuclear run-off assays. Previous investigations have shown maximum IL-2R gene induction to occur within the first 8 h after mitogenic stimulation of E+ cells, whereas maximum induction of IL-2 gene occurs several hours later (20) . We therefore examined the transcriptional activity of these genes at 8 and 24 h after mitogenic stimulation with PHA, or PHA and PMA. As shown in Fig. 6 In contrast to IL-2, nuclear transcription of IL-2R p55 at 8 and 24 h was not affected by the presence of even high dose dexamethasone (10-4 M), despite an > 80% inhibition of [3H]-thymidine incorporation, suggesting that dexamethasone does not exert inhibitory effects on IL-2Rf chain production at a transcriptional level. However, after prolonged incubation of cells (2 48 h) in the presence of dexamethasone, the transcriptional activity of IL-2R p55 was significantly inhibited (40-50%) . This is probably an indirect effect resulting from inhibition of IL-2 production which is known to increase the transcriptional activity of IL-2R p55 gene (8) . Figure 5 . Dexamethasone inhibits the production of soluble(s) IL-2R in PHA-stimulated, E-rosette-positive PBMC. Cells were preincubated with dexamethasone for 8 h, washed three times, stimulated with PHA (2 ,g/ml), and cultured for 24 h. Supernatants were collected and the soluble form of the IL-2R p55 chain was determined by an ELISA as described in Methods. Medium with or without dexamethasone resulted in < 32 U/ml in our assay.
mRNA appear within 8 h after stimulation, reach peak levels between 8 and 24 h and then decline (4, 11, 21) . The effect of dexamethasone on IL-2 and IL-2R mRNA accumulation were therefore studied at 9 h, when mRNA accumulation was maximal. High doses ofdexamethasone (10-4 M) resulted in -50% inhibition of IL-2R mRNA accumulation in a dose-dependent fashion (Fig. 7) . No inhibition was seen at 1O-6 M dexamethasone. In contrast to IL-2R, high doses of dexamethasone (l0-4 and 10-i) inhibited by 100% the IL-2 mRNA accumulation; dexamethasone at a dose of 1O-6 inhibited by > 70% the mRNA. No inhibition of IL-2 mRNA was seen at 10-9 M (data not shown).
IL-2 mRNA stability. IL-2 gene expression is regulated at either the transcriptional level or post-transcriptionally by agents which affect the stability of IL-2 mRNA (22) . The halflife of IL-2 mRNA in human peripheral blood T cells stimulated with anti-CD3 is short (t112 45 min) (22) . In the presence of PMA, a known stabilizer of lymphokine mRNA (23, 24) , IL-2 half-life is -1-2 h (25) . Since dexamethasone at 1O-6 M inhibited the nuclear transcription of IL-2 gene by -30%, whereas its effect on IL-2 mRNA was more pronounced (70% inhibition) suggesting the involvement of post-transcriptional mechanisms, we next examined the half-life of IL-2 mRNA in T cells stimulated with PHA and PMA in the presence or absence of dexamethasone (10-6 M). Transcription was interrupted 8 h after stimulation by cyclosporin A (100 ng/ml) a specific inhibitor of lymphokine gene transcription (9, 25) . The half-life of IL-2 mRNA was found to be 2.1±0.25 h (in three independent experiments) and decreased by -50% (t112 1.2±0.13 h) in the presence ofdexamethasone (Fig. 8) . Actinomycin D (10 ,ug/ml), a nonspecific inhibitor of RNA transcription, failed to inhibit the transcription of IL-2 mRNA in prestimulated cells, but not in unstimulated cells (four independent experiments, data not shown). Similar experience has been reported by other investigators who have used comparable experimental conditions (25) . Figure 6 . Effects of dexamethasone on the nuclear transcription of IL-2 and IL-2R p55 genes. E-rosette-positive human PBMC were incubated with dexamethasone for 8 h, washed, and stimulated with PHA (2 ug/ml) alone or with PMA (10 ng/ ml). Nuclei were isolated 8 and 24 h later and transcription was performed using 32P-labeled UTP. Labeled RNA was then isolated and hybridized to nylon filters onto which pBR322, GAPDH, IL-2, and IL-2R p55 plasmid cDNAs had been immobilized using a dot-blot apparatus. (19) . In addition to their transcriptional effects, steroid hormones have been reported to exert nontranscriptional effects by increasing the stability of mRNA (26) , or the translational efficiency and the stability of hormone-induced proteins (27, 28 (10-6 M) and then stimulated with PHA (2 g/ml) and PMA (10 ng/ml) for 8 h. Cyclosporine A (100 ng/ml) was added and total cellular RNA was isolated 0, 0. (31, 32) . This region is responsive to the synergistic actions of stimuli which increase [Ca2-]i and induce the activation of protein kinase C (28). These two events will in turn stimulate the production ofas yet unidentified gene products which may bind to the IL-2 regulatory region or influence the binding of other regulatory proteins to this sequence (33, 34) . In contrast to B cells, where glucocorticoids suppress the anti-Ig antibody-induced calcium mobilization (35) (30) .
Transcriptional induction of the gene encoding the a-subunit of IL-2R has been shown to be mediated by a sequence element that is homologous to the nuclear factor-KB binding site of the immunoglobulin kappa gene enhancer (37) . More recently an additional sequence motif located 10 bp downstream ofthe previously identified site has been described. Proteins binding at both sites act coordinately, leading to maximal induction of the IL-2R p55 gene (37) . IL-2R gene expression is regulated at the level of transcription and agents that activate protein kinase C only are sufficient and more potent than those that increase [Ca2+]i only to induce IL-2R p55 expression (6) .
The observed difference in the sensitivity to the inhibitory effect of dexamethasone between the IL-2 and IL-2R confirms previous reports for independent regulation of these genes.
RNA synthesis of PHA-stimulated peripheral blood lymphocytes is regulated by IL-2 (12). IL-2 augments the transcription ofseveral genes including IL-2R, c-myc, and c-myb (8, 38, 39) . Inhibition of IL-2 production by dexamethasone does not interfere with the onset of RNA synthesis and T lymphocyte activation but rather inhibits subsequent events thereby arresting cells in the Gla phase. Addition of exogenous IL-2 in the cultures reverses the inhibitory effect of dexamethasone by allowing cells to synthesize more RNA (12) . Our data on IL-2R p55 expression, whereby in the presence ofexogenous IL-2 the expression of IL-2R p55 is not inhibited by dexamethasone, echo these findings and suggest that the inhibitory effects of dexamethasone on IL-2R expression is at least in part indirect, resulting from decreased IL-2 production.
The inhibitory effect of dexamethasone on IL-2 and IL-2R mRNA accumulation is in agreement with previous reports (14) . Reed et al. (14) first observed that, whereas dexamethasone (10-6 M) significantly reduced the levels of IL-2 mRNA in PHA-stimulated peripheral blood mononuclear cells, it had no effect on IL-2R mRNA accumulation. Our data confirm their observations and offer a possible explanation for this phenomenon based on the lack ofinhibition of IL-2R gene nuclear transcription by dexamethasone. The observed decrease in mRNA accumulation of IL-2R gene at higher doses ofdexamethasone (2 1-' M) probably is nonspecific and reflects a more generalized inhibition by dexamethasone of the completion of RNA synthesis (12) . The finding that dexamethasone can alter the stability of IL-2 mRNA is novel. In addition to transcriptional post-transcriptional mechanisms have been implicated in the regulation of IL-2 gene expression (22, 25) . Addition of protein synthesis inhibitors can stabilize the IL-2 mRNA which is normally degraded by a labile RNase and thereby lead to its superinduction (4, 40) . IL-2 mRNA has at least three reiterated copies of the sequence, AUUUA, which is known to confer instability to mature mRNAs (22, 41) . Dexamethasone could change the stability of IL-2 mRNA either by inducing the synthesis of RNases or by increasing the number of AUUUA sequences in the IL-2 mRNA.
A major objective in glucocorticosteroid management of patients with immune mediated diseases is the reduction of side effects associated with their use. Alternate day glucocorticosteroid therapy has been reported to decrease significantly both the incidence and the severity of several of these complications, while at the same time being efficacious (42) . The duration of the inhibitory effect of dexamethasone on T cells (at least 72 h after the initial exposure of cells) suggests a basis for previous observations on the effectiveness of alternate day steroid therapy.
In conclusion, these studies have begun to elucidate some of the mechanisms involved in inhibition of IL-2 and its receptor by dexamethasone. By using dexamethasone as a research tool useful information may be obtained regarding the regulation of the expression of IL-2 and IL-2R genes with obvious clinical implications. Further studies are warranted to delineate the mechanism of action of corticosteroids on T cell gene expression.
